According to GenSight Biologics's latest financial reports the company's current earnings (TTM) are -$28.99 M. In 2023 the company made an earning of -$28.99 M an increase over its 2022 earnings that were of -$29.63 M.The earnings displayed on this page is the company's Pretax Income.